Skip to main content
Clinical Trials/NCT04018911
NCT04018911CompletedNot Applicable

Assessment of Novel Sound Changing Principles in Hearing Instruments to Determine Their Application

Sonova AG1 site in 1 country22 target enrollmentStarted: June 3, 2019Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Sonova AG
Enrollment
22
Locations
1
Primary Endpoint
sound quality ratings

Study Overview

Brief Summary

A methodical evaluation of novel sound changing principles in CE-labelled Sonova brand hearing instruments (e.g. Phonak hearing instruments) is intended to be conducted on hearing impaired participants. These sound changing principles are enabled by respective hearing instrument technologies and hearing instrument algorithms. The aim of the study is to investigate and asses strength and weaknesses of these novel sound changing principles in terms of hearing performance to determine their application in hearing instruments (Phase of development). Both, objective laboratory measurements as well as subjective evaluations in real life environment will be carried out. This will be a controlled, single blinded and randomised active comparator clinical evaluation which will be conducted mono centric at Sonova AG Headquarter based in Stäfa

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Treatment
Masking
Single (Participant)

Eligibility Criteria

Ages
18 Years to 99 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Healthy outer ear (without previous surgical procedures)
  • Ability to fill in a questionnaire conscientiously
  • Informed Consent as documented by signature

Exclusion Criteria

  • Contraindications to the MD in this study, e.g. known hypersensitivity or allergy to the investigational product
  • Limited mobility and not in the position to attend weekly appointments
  • Limited ability to describe listening impressions/experiences and the use of the hearing aid
  • Inability to produce a reliable hearing test result
  • Massively limited dexterity
  • Known psychological problems
  • Known central hearing disorders
  • colour blinded

Arms & Interventions

Hearing Aid standard NR_1

Active Comparator

Hearing Aid with standard Noise Reduction (NR) serves as reference condition.

Intervention: Hearing Aid with standard Noise Reduction (NR_1) (Device)

Hearing Aid with NR_2

Experimental

NR_2: Noise Reduction principle 2

Intervention: Hearing Aid with NR_2 (Device)

Hearing Aid with NR_3

Experimental

NR_3: Noise Reduction principle 3

Intervention: Hearing Aid with NR_3 (Device)

Hearing Aid with NR_4

Experimental

NR_4: Noise Reduction principle 4

Intervention: Hearing Aid with NR_4 (Drug)

Outcomes

Primary Outcomes

sound quality ratings

Time Frame: 4 weeks

The sound quality ratings will be assessed with the aid of a Multi-Stimulus Test. The data, serving as the primary outcome measure, are collected in the laboratory and will use a continuous rating scale. The scale ranges from 0 "very bad" to 100 "very good" in increments of 1.

Secondary Outcomes

  • Oldenburg sentence test & reaction time task(3 weeks)
  • Oldenburg Sentence test (Olsa)(4 weeks)
  • Adaptive Categorial Listening Effort Scaling (ACALES)(3 weeks)
  • qualitative interview form(3 weeks)

Investigators

Sponsor
Sonova AG
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Assessment of Novel Sound Changing... | Clinical Trial